Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

T helper (TH) cells are essential immune cells that help other immune cells function effectively. When activated in response to environmental stimuli, these cells can differentiate into either TH1 ...

Dr. Dr. Katelynn Ondek and Shepard, who is recovering from treatment for the neurologic form of feline in- fectious peritonitis (FIP). Katelynn Ondek, a 2010 Upper Perkiomen graduate, helped save the ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

The results of a new artificial intelligence (AI)-based tool developed by a group of physicians, scientists, and engineers at ...

12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today reported its ...

A team of clinicians, scientists, and engineers at Mount Sinai trained a deep learning pose-recognition algorithm on video feeds of infants in the neonatal intensive care unit (NICU) to accurately ...

A team of clinicians, scientists, and engineers at Mount Sinai trained a deep learning pose-recognition algorithm on video ...

In the early 2010s, Chiu, along with UCSF colleagues Joe DeRisi, Ph.D., and Michael Wilson, MD, developed a novel metagenomic ...

2022. The court documents claim the student suffered orthopedic, neurologic and emotional injuries as a result of the attack ...

The FDA has approved obecabtagene autoleucel (Aucatzyl) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

About 35% of patients diagnosed with cancer in Ontario had previously visited an emergency department, raising questions about access to routine care and oncology services.